Nov 9, 2026 7:00am EST Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights
Nov 4, 2026 7:00am EST Tonix Pharmaceuticals to Present at Guggenheim’s 3rd Annual Healthcare Innovation Conference
Nov 2, 2026 7:00am EST Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
Oct 27, 2026 7:00am EDT Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
Oct 26, 2026 7:00am EDT Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
Oct 19, 2026 7:00am EDT Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
Oct 15, 2026 7:00am EDT Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
Sep 22, 2026 7:00am EDT Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
Sep 8, 2026 7:00am EDT Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Sep 2, 2026 7:00am EDT Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference